CCHF Crimean Congo Hemorrhagic Fever RNA Detection Qualitative Test
At DNA Labs UAE, we offer the CCHF Crimean Congo Hemorrhagic Fever RNA Detection Qualitative Test. This diagnostic test is used to detect the presence of the RNA (genetic material) of the Crimean Congo Hemorrhagic Fever virus in a patient’s blood sample.
Test Details
The CCHF RNA Detection Qualitative Test is performed in our genetics department using a technique called Real Time PCR. It involves converting the viral RNA into complementary DNA (cDNA) using an enzyme called reverse transcriptase, and then amplifying the cDNA using specific primers and DNA polymerase.
The test can provide a qualitative result, indicating whether the virus is present or not in the patient’s sample. A positive result indicates an active infection with the Crimean Congo Hemorrhagic Fever virus, while a negative result suggests the absence of the virus.
The CCHF RNA Detection Qualitative Test is highly sensitive and specific, allowing for early detection of the virus and prompt initiation of appropriate treatment.
Components and Price
The cost of the CCHF RNA Detection Qualitative Test is 1160.0 AED. The test can be performed on various sample conditions, including whole blood, serum, plasma, and C.S.F.
Report Delivery
Once the test is conducted, the report will be delivered within 4th working day via email (within 48 hours) or phone (within 36 hours).
Pre Test Information
Prior to the test, patients are required to sign a consent document and provide any clinical history of the patient for CCHF. This information is crucial for accurate diagnosis and treatment planning.
Importance of the Test
The CCHF RNA Detection Qualitative Test is particularly useful in areas where the disease is endemic or during outbreaks. It helps in the rapid identification of infected individuals and implementation of necessary control measures to prevent further spread of the virus.
Early detection of the Crimean Congo Hemorrhagic Fever virus allows for prompt initiation of appropriate treatment, improving patient outcomes.
Contact DNA Labs UAE
To schedule the CCHF Crimean Congo Hemorrhagic Fever RNA Detection Qualitative Test or for any further inquiries, please contact our genetics department. Our team of physicians is dedicated to providing accurate and timely results.
Test Name | CCHF Crimean Congo Hemorrhagic Fever RNA Detection Qualitative Test |
---|---|
Components | |
Price | 1160.0 AED |
Sample Condition | Whole Blood, serum, plasma, C.S.F.etc. |
Report Delivery | 4th Working Day Email : 48 hours.On phone : 36 hours |
Method | Real Time PCR |
Test type | Viral |
Doctor | Physician |
Test Department: | Genetics |
Pre Test Information | Need to sign Consent document and bring any clinical history of patient forCCHF (Crimean Congo Hemorrhagic Fever) (RNA Detection) QualitativeTest |
Test Details | The CCHF (Crimean Congo Hemorrhagic Fever) RNA Detection Qualitative Test is a diagnostic test used to detect the presence of the RNA (genetic material) of the Crimean Congo Hemorrhagic Fever virus in a patient’s blood sample. This test is typically performed in a laboratory setting using a technique called reverse transcription polymerase chain reaction (RT-PCR). It involves converting the viral RNA into complementary DNA (cDNA) using an enzyme called reverse transcriptase, and then amplifying the cDNA using specific primers and DNA polymerase. The test can provide a qualitative result, indicating whether the virus is present or not in the patient’s sample. A positive result indicates an active infection with the Crimean Congo Hemorrhagic Fever virus, while a negative result suggests the absence of the virus. The CCHF RNA Detection Qualitative Test is highly sensitive and specific, allowing for early detection of the virus and prompt initiation of appropriate treatment. It is particularly useful in areas where the disease is endemic or during outbreaks, as it helps in the rapid identification of infected individuals and implementation of necessary control measures to prevent further spread of the virus. |